John Vissing
Impact in
- Clinical Biochemistry top 0.05%
- Metabolism and Genetic Disorders
- Neurology top 0.2%
- Myasthenia Gravis and Thymoma
Papers in
- Rheumatology 100
- Glycogen Storage Diseases and Myoclonus 97
-
- Genetic Neurodegenerative Diseases 91
- Co-authors
- Marianne Schwartz (24 shared papers)Ronald G. Haller (33 shared papers)Morten Dunø (80 shared papers)Mette Cathrine Ørngreen (48 shared papers)Nanna Witting (64 shared papers)Thomas O. B. Krag (66 shared papers)Tina Dysgaard Jeppesen (33 shared papers)David Benee Olsen (11 shared papers)
- Journals
- Neuromuscular Disorders (72 papers)Neurology (58 papers)Muscle & Nerve (24 papers)Journal of Neurology (24 papers)Annals of Neurology (20 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
John Vissing
492 papers receiving 15.0k citations
John Vissing's Hit Papers
Peers
Comparison fields: 5 of 157
- Clinical Biochemistry 1.9k
- Neurology 3.0k
- Rheumatology 2.4k
- Cellular and Molecular Neuroscience 2.5k
- Genetics 1.3k
Countries citing papers authored by John Vissing
This map shows the geographic impact of John Vissing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Vissing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Vissing more than expected).
Fields of papers citing papers by John Vissing
This network shows the impact of papers produced by John Vissing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Vissing. The network helps show where John Vissing may publish in the future.
Co-authors
The 25 scholars most cited alongside John Vissing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 516 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study Hit paper breakdown → | 2017 | 622 |
| 2 | Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 505 |
| 3 | 2002 | 477 | |
| 4 | 2018 | 276 | |
| 5 | 2004 | 236 | |
| 6 | 2019 | 206 | |
| 7 | 2003 | 188 | |
| 8 | 2006 | 180 | |
| 9 | 2003 | 166 | |
| 10 | 2007 | 162 | |
| 11 | 2013 | 159 | |
| 12 | 2006 | 141 | |
| 13 | 1996 | 139 | |
| 14 | 2006 | 139 | |
| 15 | 2003 | 135 | |
| 16 | 2011 | 131 | |
| 17 | 2017 | 131 | |
| 18 | 2010 | 129 | |
| 19 | 2020 | 128 | |
| 20 | 2002 | 126 |
About John Vissing
John Vissing is a scholar working on Rheumatology, Cellular and Molecular Neuroscience, Neurology, Clinical Biochemistry and Molecular Biology, having authored 516 papers that have together received 15.6k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (126 papers), Glycogen Storage Diseases and Myoclonus (97 papers), Genetic Neurodegenerative Diseases (91 papers), Mitochondrial Function and Pathology (79 papers), Metabolism and Genetic Disorders (59 papers), Myasthenia Gravis and Thymoma (47 papers), Neurogenetic and Muscular Disorders Research (39 papers) and Cardiomyopathy and Myosin Studies (37 papers). The work is most often cited by research in Clinical Biochemistry (1.9k citations), Neurology (3.0k citations), Rheumatology (2.4k citations), Cellular and Molecular Neuroscience (2.5k citations) and Genetics (1.3k citations). John Vissing has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Marianne Schwartz, Ronald G. Haller, Morten Dunø, Mette Cathrine Ørngreen, Nanna Witting, Thomas O. B. Krag, Tina Dysgaard Jeppesen, David Benee Olsen, Julia Rebecka Dahlqvist and Marie‐Louise Sveen. Their work appears in journals such as Neuromuscular Disorders, Neurology, Muscle & Nerve, Journal of Neurology and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.